English

Booster dose now updated against covid

VACCINES AGAINST OMICRON | New versions of the Pfizer and Moderna vaccines. (Photo/EFE)

PEOPLE OVER 12 YEARS OLD CAN NOW BE VACCINATED.

Newsroom El Comercio de Colorado

Haga click aquí para leer la versión en español

The US Food and Drug Administration (FDA) approved the booster for the new Moderna and Pfizer-BioNTech vaccines. These vaccines are already adapted to the omicron variant and its sub variants, which can be inoculated immediately. This is a booster dose that can be administered to all those who have had the vaccine or the previous booster for more than two months. Booster dose now updated against covid.

The Moderna vaccine is licensed for use as a single booster dose in people over 18 years of age. Meanwhile, the Pfizer-BioNTech vaccine is also authorized for use in children over 12 years of age. Both are directed against the BA.4 and BA.5 omicron subvariants, which are responsible for the majority of infections in the United States, and which “are expected to circulate this fall and winter,” the FDA reported.

Protection against new variants

“As we head into fall and begin to spend more time indoors, we strongly encourage anyone who is eligible to consider receiving a booster dose with a bivalent covid-19 vaccine to provide better protection against circulating variants.” currently,” said FDA Commissioner Robert M. Califf.

According to the director of the Center for Evaluation and Biological Research of the FDA, Peter Marks, citizens can “be sure” of the FDA’s decision. “It is guaranteed that the bivalent vaccines against covid-19 meet safety, efficacy and quality standards.” To evaluate the efficacy of a single booster dose of the Moderna vaccine, the FDA analyzed immune response data among approximately 600 people.

Side effects

Califf says that it was clear that the immune response of the participants who received the bivalent vaccine was better than that of those who received the Moderna monovalent vaccine. A similar number of people tried the Pfizer-BioNTech booster dose, with similarly positive results.

Among study participants who received the bivalent vaccine, the most commonly reported side effects were pain, redness, and swelling at the injection site, fatigue, headache, muscle and joint pain, chills, swelling of the lymph nodes in the injection arm, nausea, vomiting, and fever.

Booster dose now updated against covid

Who qualifies to receive the booster dose?

Persons 18 years of age and older are eligible for a single booster dose of Moderna’s COVID-19 vaccine, Bivalent if it has been at least two months since they completed the primary vaccination schedule or have received the booster dose later. with any licensed or approved monovalent COVID-19 vaccine.

Persons 12 years of age and older are eligible for a single booster dose of the Pfizer-BioNTech COVID-19 vaccine, Bivalent if at least two months have passed since they completed the primary vaccination schedule or received the booster dose. with any licensed or approved monovalent COVID-19 vaccine.